Instagram Outage Disrupts Thousands of U.S. Users 
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals 
A kind of paracetamol being marketed under the brand name Paraveganio is now available in Germany. What makes this medicine special is the fact that it is made with plant-based ingredients only, and it is the first of its kind in the world.
PlantBased News reported that the new medicinal drug is now vegan-certified and the world’s first to be registered with The Vegan Trademark, a trusted vegan labeling being managed by The Vegan Society, a recognized charity and the oldest vegan organization in the world.
Paraveganio was developed by a German pharma firm called Axunio. It was made using 100% plant-based ingredients, and it is now the first product to be certified as vegan by The Vegan Society. Paracetamol is used worldwide as a painkiller and can be purchased over-the-counter, but this medicine contains an animal-derived additive called the magnesium stearate.
Most pharma companies use this additive for lubricating properties in tablets and capsules. The stearic acid that it contains is an ingredient that is made with animal fats.
The plant-based Paraveganio paracetamol is free from magnesium stearate sourced from animals. Rather, this was taken from pure vegetable sources. Axunio guaranteed that its 500 mg. paracetamol tablets are 100% vegan drug that can be taken to relieve mild and moderate pain as well as reduce fever.
“We could not be prouder to be bringing the world’s first vegan-certified drug to the market. Of course, to have it certified by The Vegan Society’s Vegan Trademark – the gold standard in vegan labeling - makes it that much more special too,” Axunio’s product and business development manager, Julia von Horsten, said in a press release.
She added, “Many people are surprised to hear that the majority of medications, including over-the-counter products such as paracetamol, contain animal derivatives or have been tested on animals. We know there’s a gap in the market for vegan certified paracetamol and are so delighted to be able to offer our product to consumers.”
Meanwhile, this is a good innovation, but the Paraveganio tablets are only available in Germany at the moment. Then again, this may soon reach other countries as Axunio is planning to bring its vegan paracetamol to other markets too.
